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Abstract 
 The effects of oxidative damage and the mechanisms through which it is repaired 
have been a topic of intense research for several years.  Research has shown that small 
changes in the redox state of cells can lead to protein modification which, in turn, can 
result in changes in protein function and activity.  This thesis discusses the development 
of a method to study tubulin S-glutathionylation that avoids several of the inherent 
technical difficulties in studying oxidative modifications of tubulin.  Biotinylated GSSG 
(oxidized glutathione) was synthesized, purified, and incorporated into tubulin via thiol-
disulfide exchange.  S-glutathionylated tubulin was isolated on an avidin-agarose resin by 
utilization of biotin’s affinity for avidin.  This biotin affinity capture method allows for 
future quantification of S-glutathionylation in tubulin as well as exploration of its role in 
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Introduction 
Protein Oxidation  
 Aerobic respiration, the process through which humans and other higher 
organisms produce ATP, is achieved through electron transfer to oxygen and subsequent 
reduction of O2 to water.  The transfer of electrons to oxygen is highly efficient.  
However, 1-2% of electrons are leaked during this process, and reactive oxygen species 
are inadvertently produced1.  Superoxide (O2-), hydrogen peroxide (H2O2), and the 
hydroxyl radical (OH.), are the most common of these and can harmfully oxidize 
biomolecules1.  Many other biological processes in addition to aerobic respiration also 
produce reactive oxygen species.  For example, oxidative damage is often detected in 
human disease, and the proteins NADPH oxidase, lioxygenase, and cyclooxygenase have 
been reported to produce radical byproducts1.   
 Reactive oxygen species can cause considerable damage to cells via protein 
oxidation.  Generally, protein oxidation can lead to defects in conformation or tertiary 
structure that result in a decrease or complete loss of protein function2.  Additionally, 
some oxidized proteins are targeted heavily for degradation by proteinases and thus have 
a shorter lifespan than their undamaged counterparts2.  Alternatively, oxidation of 
cysteine residues, in particular, can lead to the formation of disulfide bonds between two 
or more proteins.  This creation of higher order species can result in pathological protein 
aggregates that are resistant to proteinase degredation2.  Not surprisingly, increasing or 
decreasing the natural lifespan of any protein by any mechanism can have a deleterious 
effect on the cell.  In Alzheimer’s disease this is the case, and it is protein aggregates that 
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lead to the diagnostic symptoms of amyloid plaques and neurofibrillary tangles found in 
the brain.   
 
Protein Oxidation in Alzheimer’s Disease  
 Protein deposits in the brains of Alzheimer’s patients were first detected by 
scientists in the mid nineteenth century and correlated to dementia, although their 
structure and protein composition was not understood until the 1970s3.  Neurofibrillary 
tangles are one of two types of protein deposits found throughout the brains of 
Alzheimer’s patients4.  Tangles have a distinct morphology of paired helical filaments 
that associate into a dense protein mass via non-covalent interactions.  While their protein 
composition varies, much of the aggregated protein consists of Tau, a microtubule 
associated protein.  Indeed, many inherited forms of Alzheimer’s disease are traced back 
to mutations in this protein, and a hyperphosphorylated form is thought to aggregate more 
readily4.   
 Amyloid plaques, with their beta sheet structure, are the most well studied protein 
aggregate associated with Alzheimer’s disease.  They are similar to neurofibrillary 
tangles in their defined structure and insolubility, but their primary component is the 
incorrectly cleaved amyloid precursor protein (APP) 5.  Interestingly, several sources 
have linked this pathological form of APP, also known as the Abeta peptide, to the 
oxidative damage seen in the brains of Alzheimer’s patients5.  However, the exact 
relationship between Alzheimer’s disease pathology and oxidative damage is still 
incompletely understood.   
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 Alzheimer’s patients generally show symptoms indicative of the presence of 
damaging reactive oxygen species in the brain, but it is not apparent whether these are the 
root of neurodegeneration, a step in the pathway leading towards the loss of neurons, or 
merely a side effect of the widespread neuronal cell death.   One study, which used 
carbonyl formation as a marker of oxidative damage, found that proteins associated with 
the cytoskeleton were more likely to have oxidative damage in Alzheimer’s brains2.   
Interestingly, they found oxidative damage in both degenerative and healthy neurons, 
suggesting that oxidative damage might be a causative agent in neural degeneration rather 
than just a byproduct of the process2.   Similarly, a comprehensive review of the role of 
oxidative damage in Alzheimer’s disease suggested that the formation of amyloid plaques 
and neurofibrillary tangles may be driven by intense oxidative stress7.  They postulated 
that these aggregates may merely be an oxidative species “sponge”—a hypothesis that 
challenges a body of research that implicates protein aggregates as the primary 
neurophysiological factor leading to widespread neurodegeneration.  They went further to 
identify several possible sources of reactive oxygen species in Alzheimer’s patients 
including mitochondrial malfunction, improper lipid peroxidation, and issues with cell 
cycle arrest7.   
 However, numerous other sources have suggested that oxidative damage might be 
merely a destructive byproduct of Alzheimer’s disease.  For example, several studies 
have found that mice and C. elegans over expressing the Abeta peptide show increased 
levels of protein oxidation5.  Furthermore, it has been demonstrated that one particular 
residue in the Abeta peptide, a methionine, is essential for the increased levels of protein 
oxidation seen in Abeta peptide knock up model organisms.  This suggests that there may 
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be a distinct molecular mechanism for Abeta peptide mediated oxidative damage5.  
Regardless of which point in the pathology of Alzheimer’s disease that oxidative species 
play a part, it is abundantly clear that their study is relevant and necessary.  Accordingly, 
this thesis will focus on oxidative modification of cysteines, how these changes can lead 
to alterations in the neuronal cytoskeleton, and ultimately how this understanding can 
impact the field of Alzheimer’s disease research.   
 
The Glutaredoxin System 
Cells throughout the body have pathways for returning oxidized cysteines to their 
native, reduced state.  The well studied superoxide dismutase and catalase are examples 
of general anti-oxidant enzymes that convert reactive oxygen species to less harmful 
derivatives before they cause damage1.  However, there are several systems that are 
devoted exclusively to preventing or repairing damage to cysteine residues.  The most 
important of these are the thioredoxin reductase system (TRS) and the glutaredoxin 
reductase system (GRS).  
The GRS is a system that protects and rescues sensitive cysteine residues in 
proteins from harmful oxidation, and consists of glutathione (GSH), glutaredoxin (Grx), 
glutathione reductase, and NADPH7, 8.  GSH, is a tripeptide that exists in a redox couple 
with its oxidized form, GSSG8, 9.  Because GSH can be oxidized to GSSG during times of 
oxidative stress, the cellular concentration of these species serves as a buffer that can 
regulate the oxidative state of the cell8.  That is, the reduced form of glutathione is an 
easy target that can oxidized by reactive oxygen species in place of proteins.  In the brain, 
this buffer system is particularly important because the brain has a very high 
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concentration of reactive oxygen species.  Despite being only 2% of the overall body 
weight, the brain uses 20% of the body’s oxygen, and this prolific use of oxygen leads to 
high concentrations of reactive oxygen species10.  Even further adding to the load of 
reactive oxygen species in the brain are high concentrations of polyunsaturated fatty acids 
and metal ions that can undergo radical reactions readily, hence facilitating the process of 
reactive oxygen species propagation5.  Because there are few antioxidant enzymes in the 
brain, the glutathione redox couple is the primary way through which the brain guards 
itself against oxidative damage5.   
Rounding out the GRS are several key enzymes.  Glutathione reductase reduces 
GSSG back to GSH thus maintaining the buffered state of the cell8.  This reduction uses 
NADPH as an electron donor9: 
GSSG + NADPH + H+ → 2GSH + NADP+  
Glutaredoxin is the other important enzyme in this system.  It has a disulfide bond in its 
active site which undergoes thiol/disulfide exchange to catalyze the reduction of substrate 
disulfide bonds11.   
 Grx can reduce oxidized cysteine residues that are in disulfide bonds with 
glutathione groups and can add glutathione groups to cysteine residues9.  One mechanism 
of disulfide bond reduction is thiol/disulfide exchange:  
    P(SS)+GSH=> P(SH)2+GSSG 
While this process can occur directly in the cytoplasm, the more common mechanism 
occurs through catalysis in the active site of Grx11.  The step by step mechanism for this 
process as it is catalyzed by Grx is as follows11: 
    P(SS)+Grx(red)=>P(SH)2+Grx(ox) 
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    Grx(ox)+2GSH=>Grx(red)+GSSG  
Generally, any disulfide bond can be reduced directly by the TRS12, 13.  The GRS, 
however, requires a mixed disulfide as the substrate.  Mixed disulfides are formed by 
several mechanisms, but the most straightforward is thiol/disulfide exchange12, 13:  
     PSSP+GSH => PSSG+PSH 
This initial step in the reduction of a disulfide, the addition of glutathione to a cysteine 
residue, is also referred to as S-glutathionylation.  Because S-glutathionylation, often a 
signaling mechanism, can be both catalyzed and reversed by Grx, this enzyme has 
implications in both reduction of oxidative damage and in mediating signal transduction8.   
 There are several mechanisms through which S-glutathionylation can occur, 
although the dominant form in vivo is not yet known8.  As mentioned previously, 
thiol/disulfide exchange can result in S-glutathionylation11: 
    PSH+GSSG=>PSSG+GSH 
Other mechanisms through which S-glutathionylation can occur include direct oxidation: 
    GSH+PSH=> PSSG + 2H 
and nitric oxide induction8: 
    PSNO+GSH=>PSSG+HNO 
Which mechanism dominates likely depends on cellular conditions.  For example, 
thiol/disulfide exchange can only occur when high concentrations of GSSG are present 
such as during times of oxidative stress where the GSH/GSSG ratio is low8.   
Protein Regulation by S-glutathionylation 
Somewhat analogously to phosphorylation of serine, threonine, and tyrosine 
residues, S-glutathionylation of cysteine residues has been associated with protein 
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regulation14.  S-glutathionylation (like phosphorylation) is reversible, which makes it a 
viable mechanism for cell signaling and regulation15.  This type of regulation is observed 
in many transcription factors15.  One of the first observed examples of regulation via S-
glutathionylation was in the E. coli bacterium transcription factor OxyR9.  One cysteine 
residue in OxyR undergoes a variety of post-translational modifications—oxidation to a 
disulfide, nitrosylation, or S-glutathionylation—resulting in several different active forms 
of the transcription factor.  These different forms bind DNA either at different strengths 
or at different sequences.  Thus, post-translational modification of OxyR lead to different 
transcriptional responses that depend on the level and type of oxidative stress in the cell9.   
Another early example of protein regulation via S-glutathionylation are the 
enzymes associated with glycolysis, also known as the glycolytic enzymes15.  As early as 
1984, it was noted the level of thiol-disulfide exchange effected the activity level of a few 
glycolytic enzymes.  Later study led to the discovery that five of the glycolytic enzymes 
undergo S-glutathionylation including aldolase, GAPDH, phosphoglycerate kinase, 
enolase, and pyruvate kinase.  Several of these show a reduction of activity in response to 
higher levels of S-glutathionylation15.  Because thiol-disulfide exchange leading to S-
glutathionylation occurs primarily in cells with significant oxidative stress, this regulation 
suggests that the enzymes of glycolysis are responsive to the oxidative state of the cell.  
Indeed, it would be to a cell’s benefit to lower the amount of oxidative respiration, which 
can inadvertently produce reactive oxygen species, in circumstances where oxidative 
stress is high.   
Recently, there have been many new examples of protein regulation via S-
glutathionylation.  In humans, these include protein tyrosine phosphatase, creatine kinase, 
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caspase-3, and actin9.  The role of S-glutathionylation in actin dynamics has been 
particularly well studied.  In growth factor stimulated cells where actin polymerization 
activity is high, actin has been shown to be deglutathionylated16.  This suggests that actin 
polymerization correlates inversely with the amount of S-glutathionylation16.  Other 
cytoskeletal proteins also seem to be affected by S-glutathionylation.  A recent study of 
S-glutathionylation in the central nervous system found that S-glutathionylated proteins 
are present throughout the cerebral cortex and the gray matter of the spinal cord10.  In 
particular, they found that two of the cytoskeletal proteins necessary for neuron 
viability— β-tubulin and actin—showed the highest amount of s-glutathionylation10.  
This is consistent with results from the Landino lab that show that tubulin’s ability to 
polymerize into microtubules is sensitive to the oxidative state of its cysteine residues11.     
Microtubules  
Microtubules consist of α-β-tubulin dimers arranged in a head-to-tail 
polymerization pattern called a protofilament.  The hollow microtubule structure is 
formed by the association of 13 of these protofilaments17.  Because the microtubule 
monomer is a dimer consisting of two different protein subunits, microtubules have 
polarity.  This gives them the ability to grow and shrink from either end at different rates.  
The cap of the microtubule, called the “plus” end, has an exchangeable GTP molecule 
associated with β-tubulin18.  During the process of polymerization, this GTP is 
hydrolyzed to GDP and, upon association with the α-tubulin of another monomer, the 
nucleotide binding site is no longer exchangeable18.   
Microtubule dynamics are such that microtubules can grow and shrink quite 
readily.  In a situation referred to as dynamic instability, microtubules depolymerize 
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rapidly from the plus end.  There are several factors that can lead to dynamic instability 
such as the loss of the GTP-cap18.  There are also a number of microtubule binding 
proteins that can effect the rate of assembly and disassembly of tubulin subunits.  Some 
of the most crucial microtubule associated proteins are Tau, MAP2, and MAP4, which 
comprise the tau protein family17.  Tau contributes to the stability of microtubules and 
can bind to their surface in order to facilitate formation of complex cellular structures.  
Similarly, MAP2 helps cross-link microtubules to other microtubules and to intermediate 
filaments.  The microtubule binding ability of microtubule associated proteins is 
mediated by their reversible phosphorylation, and several kinases are responsible for 
regulating the assembly, disassembly, and maintenance of microtubules.  In processes 
that require extensive microtubule mobility, such as mitotic cell division, MAP kinases 
are activated to initiate rapid microtubule dynamic changes17.  However, there are a 
number of non-MAP related regulators of tubulin polymerization besides the microtubule 
associated proteins, including alterations to individual protein residues.   
S-glutathionylation and Tubulin 
Research suggests that S-glutathionylation is involved in microtubule 
polymerization regulation.  The Landino lab has demonstrated that tubulin shows 
decreased polymerization activity following peroxynitrite damage.  Tubulin’s 
polymerization ability was restored by addition of the GRS components7, 11.  This 
demonstrates that tubulin’s cysteines are substrates for the GRS.  Furthermore, following 
oxidative damage by ONOO- and treatment with glutathione, tubulin shows S-
glutathionylation of cysteine residues11.  As this S-glutathionylation was correlated with a 
decrease in tubulin’s polymerization ability, this suggests that S-glutathionylation is a 
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player in the regulation process of tubulin polymerization and, as follows, also 
microtubule polymerization.   
From a structural and biochemical standpoint, it is plausible that tubulin 
polymerization could be affected by S-glutathionylation.  Since the early 1990’s, 
tubulin’s sulfur based residues have been suggested as targets for anti-cancer and 
antimicrobial agents that would halt microtubule polymerization19.  Furthermore, 
tubulin’s polymerization abilities are tied to its three dimensional structure20.  Ravelli et 
al. found that a common inhibitor of tubulin polymerization (a chemotherapeutic 
molecule), Colchicine, functions by preventing tubulin dimers from forming a straight 
conformation.  They demonstrated with crystal structures that a curved conformation of 
tubulin cannot polymerize20.  Thus, the three dimensional shape of the dimer is absolutely 
critical for proper microtubule formation.  As post-translational modifications of proteins, 
such as S-glutathionylation, can alter protein conformation it is logical that they could 
have an effect on the ability of tubulin to polymerize.  Indeed, there are examples of 
cytoskeletal proteins that have altered polymerization abilities upon reaction with 
glutathione16.   
Studying Tubulin S-glutathionylation 
While S-glutathionylation has been observed in tubulin, it has not yet been 
quantified11.  There are 20 cysteine residues present in tubulin, and understanding the 
specificity of their S-glutathionylation in response to oxidative stress is important to 
further elucidate the mechanism through which microtubule polymerization is 
regulated11.  Furthermore, little is known about the selectivity of S-glutathionylation in 
any system, thus quantifying this process in tubulin would be beneficial to scientific 
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knowledge in general15.   Ultimately, understanding the interplay between microtubule 
polymerization and oxidative stress will further benefit research in neurodegenerative 
disorders.   
 Studying tubulin S-glutathionylation from a biochemical perspective has several 
inherent challenges.  Tubulin, due to the reactivity of its cysteines, tends to form disulfide 
bonds with other tubulin subunits under oxidative conditions.  If a sample of tubulin is 
run on SDS-PAGE under non-reducing conditions, the result is a difficult to interpret 
smear.  Biochemists avoid this issue by adding a reducing agent to a tubulin sample prior 
to running on SDS-PAGE which eliminates these higher order species.  However, this is 
not possible when studying S-glutathionylation as addition of reducing agent would 
remove the attached glutathione groups.  Thus, if S-glutathionylated tubulin is run under 
reducing conditions any tag that could be used for detection of S-glutathionylation would 
be lost prior to running the gel.  One way to avoid this problem is through use of 
biotinylated glutathione.   
 Biotin, also known as vitamin H, has an extremely high affinity for the protein 
avidin21.  Because of this affinity and because biotin can be easily attached to 
biomolecules without disrupting their reactivity, biotin is typically used as a tag that 
allows for later separation of tagged species21.  Attaching biotin to a molecule is known 
as biotinylation, and modifications of biotin’s valeric acid side chain can facilitate the 
biotinylation process21.  A common alteration of the valeric acid side chain is to add an 
NHS group, a highly efficient leaving group.  This addition makes the biotinylation of 
primary amines, a schematic of which is shown in Figure 1, highly efficient.  Because 
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oxidized and reduced glutathione has a free primary amine, this process can be used to 
biotinylate the primary amines of oxidized glutathione.   
Reduced glutathione has one primary amine that can be biotinylated.  GSSG, the 
oxidized form of GSH, is composed of two GSH sub-units attached by a disulfide bond 
and thus has two primary amines that are open to biotinylation.  The following 
summarizes the biotinylation reaction between GSSG and NHS-biotin 
   GSSG + 2NHS-biotin=> biotin-GSSG-biotin +NHS 
This reaction can also yield a singly tagged product in addition to the doubly tagged 
oxidized glutathione22.  One can also synthesize BGSH by this method, but because 
BGSH air oxidizes readily to BGSSGB, it is more efficient to produce BGSSGB directly.   
 Biotinylated GSSG, abbreviated BGSSGB, can easily be incorporated via thiol 
disulfide exchange into tubulin.  Because of biotin’s high affinity for avidin, the S-
glutathionylated tubulin can be isolated from unmodified tubulin by incubation with an 
immobilized avidin resin.  Treatment with DTT will reduce the disulfide bond between 
the GSH and tubulin and thus release the tubulin from the immobilized avidin.  The 
tubulin can then be analyzed further by SDS-PAGE or isoelectric focusing.  This method 
essentially “fishes” for S-glutathionylated protein thus avoiding issues with tubulin 
smearing and loss of label following reduction.  The following thesis presents a 
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Materials and Methods 
Reagents 
 Oxidized glutathione , monoclonal anti-β-tubulin antibody, HABA dye, avidin 
protein, and anti-mouse IgG peroxidase were purchased from Sigma.  NHS-biotin, 
Hypersep C18 solid phase extraction columns, and Supersignal West Pico 
chemiluminescent substrate were purchased from Thermo Scientific.  Rapid fixer and 
Industrex manual developer were purchased from Kodak.  The C8 solid phase extraction 
columns were purchased from Alltech.  The avidin-HRP conjugate, the immobilized 
Neutravidin biotin binding resin, and the BCA assay were purchased from Pierce.  All 
other reagents were from Fisher.   
Purification of Tubulin 
 Tubulin was purified from porcine brains (Smithfield Packing Company) by Lisa 
Landino as outlined in Landino et. al23.   
BGSSGB Synthesis  
 BGSSGB was synthesized by reaction of 125 µL of 100 mM NHS-biotin (DMF 
as solvent) with 312.5 µL 20mM GSSG (dH2O as solvent) in 812.5 µL 50 mM phosphate 
buffer  pH 8.0.  Final reactant concentrations were 10 mM NHS-biotin and 5 mM GSSG.  
In this scheme, there are two moles of NHS-biotin per mole of GSSG, thus both reactants 
will be completely consumed if the reaction goes to completion.  Reaction was complete 
after 18 hours incubation at 37°C.  Reaction completion was verified via thin layer 
chromatography.  TLC solvent composition was acetonitrile | H2O | acetic acid (80:20:1).  
The free amines of unreacted GSSG were visualized on the TLC plate via ninhydrin 
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spray (1% ninhydrin in 90% methanol) followed by heating.  The disappearance of the 
GSSG spots was indicative of reaction completion as the addition of biotin blocks the 
free amine.  
BGSSGB Purification 
 BGSSGB was purified via solid phase extraction columns.  All columns were 
conditioned by washing with 2 mL methanol followed by 2 mL H2O.  After collecting the 
load eluent as fraction 1, each column was washed with 1 mL H2O twice (fractions 2 and 
3) and 1 mL MeOH twice (fractions 4 and 5).  To purify BGSSGB from the unreacted 
NHS-biotin and the singly tagged BGSSGB product, the reaction mixture was run 
through a C8 column and fraction 2 saved.  This fraction was then run through a C18 
column.  Fraction 2 from this second separation contained pure BGSSGB and was saved.  
HABA assays were used to determine which fractions contained biotin or biotinylated 
species.  Thin layer chromatography was used as described previously to detect presence 
of GSSG or the singly tagged product, BGSSG, in fractions.   
Measurement of BGSSGB Concentration via Reduction to BGSH 
 Aliquots of the BGSSGB containing fractions were reduced to BGSH by addition 
of DTT to a final concentration of 100 mM.  A C18 column was used to separate BGSH 
from DTT.  The reduced reaction mixture was acidified to a concentration of 0.1% acetic 
acid.  The H2O and MeOH used for fractionation were acidified to the same 
concentration.  After column conditioning, the acidified reaction mixture was fractionated 
over a C18 column.  Water washes were continued until fractions were clear of DTT.  
DTT presence in fractions was assayed by the BCA protein reagent.  Generally, at least 
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20 washes of 1 mL each were required for complete removal of reducing agent.  BGSH 
elutes in the first methanol wash, which was dried via Speed Vac, and resuspended in 
desired volume of 0.1M phosphate buffer pH 8.0.  After resuspension, BGSH requires 
storage at -20° C to prevent oxidation to BGSSGB.   
A DTNB assay was used to determine the concentration of BGSH in the sample.  
A GSH standard curve (absorbance measured on 96 well plate reader) was generated and 
used to convert sample absorbance values to concentrations of free thiol.  This 
determined concentration of BGSH was converted to moles, and is approximately two 
times the amount of BGSSGB in the fraction prior to reduction.  Thus, BGSH 
concentration can be used to estimate the concentration of BGSSGB in the original 
sample and the percent yield of the reaction after purification.   
HABA Assay to Determine Presence of Biotin in Column Fractions 
 To test for the presence of biotin or biotinylated species in the solid phase 
extraction column fractions, fractions were diluted 1:20 with 0.1 M phosphate buffer  pH 
7.4.  90 µL of avidin/HABA solution (0.5 mg/mL avidin and 0.3 mM HABA dye in 50 
mM phosphate buffer pH 7.4) was combined with 10 µL of the diluted fraction.  Color 
change from orange to bright yellow indicated the presence of biotinylated species or 
pure unreacted biotin.  Fraction dilution factor was adjusted if necessary to achieve 
sufficient contrast between fractions.     
Reaction of Protein (Model or Tubulin) with BGSSGB 
 To S-glutathionylate protein, 20 µL 4 mg/mL tubulin or 2 mg/mL model protein 
(either GAPDH, CK, ADH, LDH, or Papain) was combined with 10 µL of ~1.5 mM 
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BGSSGB or 10 µL 0.1 M phosphate buffer  pH 8.0 for controls.  Samples were incubated 
for 20 minutes at 37°C. 
Ethanol Precipitation  
200 µL cold (-20°C) ethanol was added to protein samples that had completed their 
incubation with BGSSGB.  Samples were incubated for 20 minutes at -20 °C, and the 
precipitated protein was pelletted via centrifugation (14,000 RPM on Eppendorf 
centrifuge 5415C for 5 minutes).  Supernatant was pipetted off, and 1 µL of 10% SDS 
was pipetted directly on to the pellet to facilitate resuspension.  The pellets were 
resuspended in 30 µL 0.1 M phosphate buffer  pH 8.0 and allowed to incubate overnight 
at 37°C to ensure that all protein was completely solvated.   
Isolation of S-glutathionylated Tubulin with Avidin-agarose Resin 
 The samples were increased in volume by the addition of 30 µL of 0.1 M 
phosphate buffer pH 8.0.  The avidin-agarose resin was suspended by inversion 10 times.  
Prior to its addition to each sample, the resin was inverted 3 times to ensure uniform resin 
density in the slurry.  20 µL of resin slurry was added to each sample, and the samples 
mixed on a rotator for 24 hours at room temperature.  Following incubation, each sample 
was centrifuged for 5 minutes at 14,000 rpm to pellet the resin.  The supernatant was 
carefully pipetted off without disturbing the pellet.  The pellet was then rinsed twice (400 
µL of 0.1 M phosphate buffer pH 8.0 was added to each sample and mixed via vortex.  
The resin was then again pelletted and the supernatant carefully pipetted off).  After 
rinsing, the resin pellet was suspended in 30 µL of 50 mM DTT with 0.1% SDS and 
	   19	  
incubated for 1 hour at 37°C.  The entire sample, including resin, was then loaded onto a 
gel for SDS-PAGE.   
SDS-PAGE and Western blots of Tubulin and Other Model Proteins 
 Samples were analyzed by SDS-PAGE on 10% polyacrylamide gels.  Gels 
containing tubulin were run under reducing conditions whereas model protein sample 
containing gels were run under non-reducing conditions.  Tubulin gels were visualized 
either via Western blot or via Coomassie blue staining.  For the western blots, proteins 
were transferred to PVDF membranes via the Panther semi-dry transfer apparatus.  For 
tubulin visualization, a mouse anti β-tubulin antibody was the primary antibody followed 
by goat anti-mouse HRP-conjugated secondary antibody.  For model proteins, bands 
were transferred to a PVDF membrane as described above, and S-glutathionylation was 
detected directly via avidin-HRP conjugate (which binds to the biotin labeled glutathione 
via the avidin-biotin interaction).  In both cases, a chemiluminescent substrate was 
ultimately used for visualization.   
Dot Blots 
 Dot blots were used as a method to quickly detect the presence of protein or S-
glutathionylation.  1.5 µL of sample was dotted onto nitrocellulose membrane followed 
by blocking with 3% milk.  Spots were assayed for presence of β-tubulin or biotinylated 
glutathione via the detection methods outlined above.  
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Results and Analysis 
Synthesis and Purification of BGSSGB 
 We synthesized biotinylated oxidized glutathione (BGSSGB) and purified it from 
other reaction species via a solid phase column chromatography approach.  Synthesis of 
BGSSGB was attempted using the protocol found in Sullivan et al., although this 
protocol was ultimately abandoned22.  There were several challenges in generating a 
sufficient yield of BGSSGB.  NHS-biotin is insoluble in water and thus must be first 
dissolved in DMF before it can be incorporated into the reaction mixture.  Because DMF 
contains a carbonyl, it is a potential target of the nucleophilic amine in GSSG and can 
compete with NHS-biotin.  Because this secondary product is undesirable, the amount of 
total DMF in solution had to be carefully controlled.  Excess DMF can also alter the 
polarity of the reaction mixture, which can effect the later purification process.  
Furthermore, the reaction will only proceed in 0.1 M phosphate buffer .  The use of other 
buffers, such as ammonium bicarbonate, lead to extremely low yields.  As of present, it is 
not clear why buffer choice is so critical.    
Figure 2 shows a TLC plate visualized with ninhydrin solution that demonstrates 
the successful completion of the reaction.  In the control lane, which consists of a GSSG 
only solution, unmodified GSSG is seen as a bright spot that migrates only slightly.  Lane 
2 shows the reaction mixture which lacks unreacted GSSG and in which a singly tagged 
product, BGSSG, has migrated halfway up the plate.  This presence of an intermediate 
product and absence of unreacted GSSG shows that the reaction has gone to completion.  
One would not expect to see any spot corresponding to the doubly tagged product 
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(BGSSGB) as it lacks free amines.  Figure 3 summarizes the various species present in 
the reaction mixture and their appearance on a TLC plate.   
 We separated the reaction species via solid phase column chromatography.  The 
initial separation was achieved with a C8 column, which elutes species in order from 
most polar to least polar. Thus, according to theory, any unreacted GSSG should elute 
first, the singly tagged product (BGSSG) second, the doubly tagged product (BGSSGB) 
third, and the unreacted NHS-biotin last.  The TLC plate results (Figure 2) demonstrate 
this separation which occurs according to these theoretical predictions.  As the entire 
reaction TLC plate shows only singly tagged product and no unreacted GSSG, we 
expected to only see BGSSG on the TLC plates of various fractions.   
 Fractions 3 (water), 4 (methanol), and 5 (methanol) show no free amine 
containing species on the TLC plate, indicating that those fractions could only potentially 
contain either unreacted NHS-biotin or the doubly tagged product (BGSSGB).   
However, the HABA assay (Figure 4) of these fractions shows that biotin was present 
only in fraction 2 (water).  Thus fractions 3 (water), 4 (methanol), and 5 (methanol) 
contained neither unreacted biotin nor BGSSGB.  Generally, unreacted NHS-biotin elutes 
in fraction 4 (methanol), and its absence from that fraction gives further evidence for the 
completion of the reaction.  Figure 5 shows the HABA assay controls for comparison of 
intensity.   
 In Figure 2, the TLC plate of fraction 1 (load eluent) shows a large amount of 
BGSSG while fraction 2 (water) shows a significantly smaller amount of BGSSG.  The 
HABA assay of these fractions (figure 4) shows that biotin is present in fraction 2 (water) 
and very slightly present in fraction 1 (load eluent).  Because the HABA assay indicated 
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that the bulk of the biotin labeled species were present in fraction 2 (water), we 
concluded that fraction 2 (water) contained the desired doubly tagged product and a small 
amount of the singly tagged product.  Fraction 1 (load eluent) contains most of the 
BGSSG, which explains its slight positive in the HABA assay.  Figure 6 is a tabulation of 
the TLC and HABA results for the C8 column separation for the whole reaction, assorted 
controls, and each fraction from the C8 column separation.   
 A C18 column was used to separate the components of the C8 column fraction 2 
(water) in order to separate the BGSSGB from the contaminant singly tagged product.  
Like the C8 column, the C18 column stationary phase retains non-polar species longer 
than polar species.  However, the C8 column stationary phase is more polar than the C18 
stationary phase, thus retention times differ across the two columns.  Thus, according to 
this theory, the singly tagged product should elute before the doubly tagged product, and 
the change in stationary phase polarity will allow the two compounds to elute in different 
fractions.   
 Figure 7 shows the TLC plate of the C18 column fractions.  There are no species 
visible in any fraction, which suggests that the amount of singly tagged product present in 
this fraction was negligible.  HABA assay (figure 8) shows that biotin is present only in 
fraction 2 (water).  As the TLC plates demonstrate that this cannot correspond to the 
singly tagged product, it was concluded that this fraction contained the desired product, 
BGSSGB.   Figure 9 summarizes the HABA assay and TLC plate results for the C18 
separation.  Figure 10 is a theoretical schematic showing the likely distribution of species 
by fraction in each separation. 
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Quantification of BGSSGB 
The amount of BGSSGB in the pure fraction was quantified via DTNB assay.  
The DTNB reagent reacts with free thiols to generate a measureable change in 
absorbance.  In order to use this method BGSSGB was reduced to BGSH with DTT.  
Because DTT contains a free thiol and could interfere with the results of the DTNB 
assay, the reducing agent was separated from the BGSH via a solid-phase column 
extraction.   
This separation was unexpectedly challenging.  The Landino lab routinely 
separates flourescein tagged glutathione, or FGSH, from DTT via a C18 column 
extraction, but this protocol was unsuccessful when applied to BGSH24.  While FGSH 
elutes in the methanol fractions and the reducing agent in the water fractions, the BGSH 
eluted with the reducing agent in the water fractions.  This difference in elution is 
probably due the polarity difference between flourescein and biotin.  With several 
secondary amines, biotin is more polar than flourescein, and biotinylated species are thus 
more likely to be only weakly retained by the non-polar C18 column used in the 
separation.  This issue was addressed by acidification which decreased the polarity of 
BGSH via protonation.  After this change, the BGSH eluted in the methanol fractions 
allowing for the separation of BGSH from DTT.   
 The concentration of BGSH in the assayed sample was found to be 1.2 mM.  
After accounting for dilution factors and various conversions, the amount of BGSSGB in 
the purified fraction was found to be 1.44 x 10-6 moles or 1.44 mM.  Based on the 
concentrations of GSSG and NHS-biotin in the original reaction, the theoretical yield of 
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BGSSGB is 5.0 x 10-6 moles or 5.0 mM in the 1 mL fraction.  This gives a percent yield 
for the BGSSGB synthesis reaction after purification of 71%.   
The calculated concentrations of BGSSGB via DTNB assay are meant only to be 
approximations of overall concentration.  As the DTNB assay measures free thiol 
concentration, it has no way of distinguishing between GSH and BGSH.  If there were 
any remnants of BGSSG in the purified fraction, reduction would generate a BGSH 
molecule and a GSH molecule.  In this situation, the DTNB assay would indicate a higher 
concentration of BGSSGB than was actually present in the original purified fraction.  
Furthermore, DTT contains a free thiol, and if any DTT contamination would introduce 
error.  The complexity of the reduction and purification procedure also likely contributes 
significantly to error.  However, despite these limitations, the results of this assay 
considered together with the TLC plate and HABA assay data) indicate that the BGSSGB 
synthesis reaction went to completion and was separated to reasonable purity via solid 
phase chromatography.   
Development of Biotin Affinity Capture Method 
 As was discussed in the introduction, it is difficult to study S-glutathionylation in 
tubulin directly via Western blot.  Figure 11 demonstrates the issues inherent in running 
tubulin on SDS-PAGE under non-reducing conditions.  While the intensity of the bands 
shows that BGSH has been incorporated into tubulin via thiol/disulfide exchange with 
BGSSGB (i.e. S-glutathionylation has occurred), it does not give any sort of information 
as to which sub-unit of tubulin was modified.  Indeed, the tubulin runs as a large smear in 
which the α and β subunits are impossible to distinguish.  Thus, this indicates the 
necessity for development of an alternative protocol to explore S-glutathionylation.   
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 The developed protocol can be carried out over several days.  Tubulin is 
incubated with BGSSGB for 30 minutes followed by an ethanol precipitation to separate 
protein from excess reagent.  Resuspension of S-glutathionylated tubulin in phosphate 
buffer requires the addition of a small amount of SDS and incubation over night.  
Resuspended protein is then incubated on a turner for 24 hours with 20 µL of avidin-
agarose resin in addition to 30 µL of phosphate buffer to increase the overall reaction 
volume.  After incubation, the resin is washed with phosphate buffer twice (the pellet 
containing the resin and modified tubulin is retained) and then reduced by DTT for 2 
hours.  This reduced sample can be run, still containing the resin, on an SDS-PAGE gel 
under reducing conditions.   
There were several inherent challenges in developing this affinity capture of 
biotin protocol as it is presented above.  First, S-glutathionylated tubulin is difficult to 
resuspend following ethanol precipitation.  Without the addition of a small amount of 
SDS and incubation at 37ºC, tubulin can take several days to resuspend.  Indeed, even 
with these conditions designed to promote solvation of protein, resuspension requires at 
least twelve hours.  Second, because reaction volumes are so small and surface tension is 
significant, sufficient sample mixing was an issue.  Incubating a 30 µL sample on a 
rotating mixer for 48 hours did not result in sufficient mixing for biotinylated tubulin to 
be retained by the avidin-agarose resin.  Due to economic concerns, the amount of tubulin 
and resin per sample could not be increased, and a wide variety of unsuccessful 
approaches to circumvent this limitation and increase mixing were attempted.  
Ultimately, increasing reaction volume with the addition of buffer enough to facilitate 
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mixing, but not so much as to over-dilute reaction components, was sufficient for 
biotin/avidin binding. 
Figure 12 represents the successful incorporation of biotinylated glutathione into 
tubulin and the isolation of the modified tubulin from the bulk reaction mixture via 
avidin-agarose resin.  The two bands present in each sample lane (which have identical 
composition) represent α and β-tubulin, and the amount of protein retained by the resin is 
comparable across both samples.  Because α- and β-tubulin are associated until 
denaturing, these two species will always elute together from the avidin-agarose column.   
Figure 13 summarizes the assorted controls.  The “no resin control”, to which 
BGSSGB but not the avidin-agarose resin was added, shows only a very light band.  This 
demonstrates that the amount of protein clinging to the side of the microfuge tube is 
negligible and that the protein retained by the resin in the sample lanes is significant.  The 
“no BGSSGB control”, to which the avidin-agarose resin but not BGSSGB was added, 
similarly shows only a light band.  This demonstrates that the resin retains only that 
protein which is modified by a biotinylated glutathione molecule.  The “tubulin only 
control” is representative of the initial concentration of tubulin added to the reaction 
mixture and serves as a guide to estimate the percentage of tubulin that is ultimately 
retained by the avidin-agarose resin.   
 In order to verify the success of the protocol, a series of dot blots were performed 
at key steps.  Figure 14 shows dot blots taken before and after the ethanol precipitation.  
Biotin is visualized, thus the reduction in the size of the spot from incubation to post 
precipitation demonstrates the success of the ethanol precipitation in removing excess 
BGSSGB.  Worth note, however, is the aberrant spot in the “no BGSSGB control” after 
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resuspension.  This false positive can likely be attributed to avidin-HRP’s tendency to 
sometimes loosely bind to non-biotinylated species.  Figure 15 shows the same dot blots 
again, although in these β-tubulin is visualized.  While there is some reduction in spot 
intensity from reaction to post incubation, the presence of protein following ethanol 
precipitation demonstrates that resuspension was successful and did not result in a 
significant loss of tubulin.   
 Figure 16 shows dot blots, with biotin visualized, from the reaction taken after 
incubation with the avidin-agarose resin and from the first wash supernatant.  After 
incubation with the resin, the “no resin control” has a larger spot size than either of the 
experimental samples.  This shows that the presence of resin leads to a reduction in the 
amount of biotinylated species present, indicating that in the experimental samples a 
portion of the biotinylated tubulin has been bound by the resin.  The blots of the first 
wash show a significant reduction in the amount of biotinylated tubulin present, which is 
expected given the wash’s dilution compared to sample size.   
Estimation of Amount of Tubulin S-glutathionylation 
 Estimation of band intensities between the two tubulin sample lanes and the 
tubulin only control lanes (Figures 12 and 13) suggests that perhaps 10-20 percent of the 
total tubulin is retained by the avidin-agarose resin.  However, it is likely that somewhat 
more than 10-20 percent of the tubulin is S-glutathionylated as Figure 16 shows that 
some biotinylated species are not bound by the avidin-agarose resin.   
 It is expected that total S-glutathionylation of tubulin would be low.  Tubulin has 
20 cysteines, but not all are displayed on the surface and, as will be discussed in detail in 
the next section, it is possible that some of these cysteines could be blocked by 
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participation in disulfide bonds between protein subunits.  Furthermore, as S-
glutathionylation is reversible and dynamic, there is no guarantee that residues that are 
initially S-glutathionylated remain modified.  Thus, the low yield of glutathionylated 
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Discussion and Future directions 
Evaluation of Affinity Capture Method 
 There are a number of strengths and weaknesses with the developed affinity 
capture method.  Its most obvious advantage is the ease in which it can be carried out.  
Tubulin does not need to be in its native state in order to carry out this analysis, which 
allows for considerable freedom in reaction conditions and sample work up.  
Furthermore, the amount of time required, relative to other methods, is quite low.  One 
particularly apparent time advantage occurs in the capability of using Coomassie blue 
staining over a Western Blot to visualize SDS-PAGE results.  The biotin affinity capture 
method is also relatively cheap and requires little in the way of instrumentation.  Other 
methods of studying structural changes to a protein, such as mass spectrometry or x-ray 
crystallography, require advanced instrumentation that is not always available to every 
researcher.  This method, on the other hand, requires instrumentation that nearly every 
biochemistry lab possesses and requires only basic biochemical technical skills.   
 However, there are a several disadvantages to this method.  First, it is difficult to 
know how much of the protein is actually modified.  Certainly, one can gain 
understanding of relative amounts of S-glutathionylation across a variety of reaction 
conditions with this method.  However, given the number of steps and complexity of the 
procedure, it is likely that a considerable amount of modified protein is lost throughout 
the process.  Lane 1 in figure 13 is unmodified, reduced tubulin at the same concentration 
as the initial tubulin concentrations of the sample lanes.  It is clear that the magnitude of 
tubulin present after the biotin affinity capture method is dramatically lower than when 
tubulin is run without modification.  Whether this reduction in the amount of tubulin 
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present is due to protein loss during the procedure or simply low levels of BGSH 
incorporation is difficult to distinguish.  It would be very useful to corroborate this 
experimental method with another, such as mass spectrometry, to get a sense of how 
much of the modified protein is actually retained and visualized.   
 Another issue is the undesirable types of tubulin oxidation that occur in the 
reaction with BGSSGB.  The addition of BGSSGB, an oxidant, to tubulin leads to the 
formation of higher order protein structures.  This was demonstrated in figure 11, which 
shows the smearing of tubulin when it is not run under reducing conditions.  If so much 
tubulin aggregation is occurring via disulfide bond formation, many cysteines that may 
usually be available for post translational modification are trapped in disulfide bonds 
between protein molecules.  This very likely changes the amount of S-glutathionylation 
that occurs in vitro compared to what occurs in vivo and could lower the yield of S-
glutathionylated protein.  There are several ways this issue could be addressed, such as 
alteration of reaction conditions to more closely mimic in vivo environments, that should 
be pursued in future experiments.   
Future Experiments Using Biotin Affinity Capture Method  
 Despite several weaknesses that should be further explored, this method is first 
step in carrying out a number of interesting and useful experiments to study S-
glutathionylation.  Previous work in the Landino lab has quantified tubulin thiol/disulfide 
exchange with flourescein labeled glutathione using an HPLC approach, and it would be 
relevant to expand these results11.  A simple experimental approach that utilizes the biotin 
affinity capture method would be to determine whether the magnitude of S-
glutathionylation changes in response to different reaction conditions such as differing 
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pH or amount of oxidant present.  One could also design in vitro experiments that more 
mimic the cellular environment and thus generate a more realistic predictor of the amount 
of S-glutathionylation that actually occurs in vivo.  An interesting approach would be to 
determine whether addition of several of the enzymatic components of the GRS, such as 
glutathione reductase, could yield increased S-glutathionylation.   
 A more challenging, but possibly more rewarding application of the biotin affinity 
capture method would be analysis of modified tubulin fragments following protease 
digestion. If the protease was chosen carefully, digestion post reaction would yield a 
series of segments of known composition and length.  That is, when proteases that cut at 
only particular sequences were used, one could predict the number and identity of 
cysteines in a segment of a particular length.  Only those segments that possessed a 
cysteine that was modified by glutathione would be retained by the avidin agarose resin, 
and SDS-PAGE of the reduced resin mixture would yield a series of protein segments 
that could be identified based on their molecular weight.  These segments that appeared 
on the gel would correspond to the segments containing a modified cysteine.  Thus 
through a series of different digestions one could piece together which cysteines are 
modified preferentially.  As determining which specific cysteine residues are modified is 
possible only through three dimensional structural analysis, which is difficult and time 
consuming, this technique would be an extremely useful angle to pursue.   
 Take a theoretical example: perhaps one wanted to analyze the cysteine residues 
in β-tubulin that could be critical for regulating polymerization.  Cys 12, cys 129, and cys 
131 are three surface cysteines that three dimensional structural analysis show to be 
relevant.  Figure 17 shows these cysteines in the three dimensional structure of tubulin.  
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As can be seen in this figure, cys 12 is located in very close proximity to the GTP binding 
site in β-tubulin.  Modifications to cys 12 with glutathione could lead to alterations of 
GTP binding abilities or GTP hydrolysis.  As discussed in the introduction, the GTP cap 
of microtubules is closely related to microtubule dynamics and stability, and any 
modification that altered this system could have dramatic effects on microtubule 
polymerization ability.   
 As is seen in figure 17, cys 129 and 131 are in close proximity to one other.  This 
proximity suggests that they could participate in a disulfide bond, although x-ray 
crystallography data indicates that in free tubulin no bond forms18.  As disulfide bond 
formation can result in dramatic changes in tertiary structure, it is conceivable that S-
glutathionylation of one of these residues (which would block disulfide bond formation) 
could lead to substantial changes in the structure of tubulin.   
 With these key cysteines in mind, it is relatively simple to use proteolytic 
digestion to generate peptide chains of known length that contain the cysteines in 
question.  To isolate cys 12, one could use Carboxypeptidase Y from baker’s yeast, 
which cuts only between two aromatic residues, to cut between tyr 52 and tyr 53.  This 
would yield a 51 amino acid long peptide containing cys 12 that could be identified on a 
gel with the assistance of a molecular weight ladder.  If cys 12 was modified by 
glutathione, this peptide would appear on SDS-PAGE after the entire digested sample 
was incubated with avidin-agarose resin.   
 Similarly, one could generate a peptide containing cys 129 and 131 using 
Pancreatic Elastase which cuts only after alanine residues.  A protease that cuts only at 
alanine would generate a series of peptides including a 75 amino acid residue containing 
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cys 129 and 131.  While using this approach would not be able to distinguish whether cys 
129, cys 131, or both were S-glutathionylated, the presence of any S-glutathionylation 
could indicate the possible disruption of a disulfide bond25. 
Future Investigations of Tubulin S-glutathionylation 
 There are a number of future directions this research could lead.  As discussed in 
the introduction, there are many diseases in which oxidative damage is a primary 
symptom.  In Alzheimer’s disease, for example, oxidative damage is an area of increasing 
focus.  Understanding tubulin's activity in response to oxidative changes in the cell is thus 
an extremely valid approach to addressing Alzheimer’s treatment.  If cysteine residues 
key to tubulin polymerization are S-glutathionylated with specificity under conditions of 
oxidative stress, this could be a key target for an anti-neurodegeneration drug.   
 An understanding of how tubulin is S-glutathionylated could also lead to a 
number of new investigations in the field of anti-cancer drugs.  One especially interesting 
field to explore is the use of cysteine residue modification as a way to target actively 
dividing cancer cells26.  A number of anti-tumor drugs such as Vincristine, Vinblastine, 
and Colchicine bind reversibly to tubulin to prevent the formation of mitotic spindles 
during mitosis.  Because of the effectiveness of these drugs, other methods of modifying 
tubulin are being explored—especially those involving cysteine modification.  One of 
these methods is alkylation of tubulin cysteine residues.  This method is an effective way 
of inhibiting microtubule polymerization but is so non specific that it is not a feasible 
approach for pharmaceuticals26.  Thus, other cysteine modifications need to be examined, 
and understanding the process of tubulin S-glutathionylation could lead to the discovery 
of potential targets for anti-tumor drugs.  If tubulin polymerization is indeed partially 
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regulated by S-glutathionylation, anti-cancer drugs could be developed that either mimic 
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Conclusion 
 The study of S-glutathionylation in tubulin is relevant both to improving general 
knowledge and furthering biomedical research.  It falls within the broad field of oxidative 
signaling that is of great interest currently both in terms of biomedical research and in 
cell biology.  More specifically, its focus on tubulin is very appropriate, as understanding 
microtubule polymerization is essential to combating the prevalent neurodegenerative 
disorders that involve the malfunction of this process.   
 The presented biotin affinity capture method is an effective way of further 
probing this field.  In addition to circumventing several of the inherent challenges in 
studying oxidative modifications to tubulin, it is inexpensive and simple.  Whether it is 
used as a method to directly study the regioselectivity of S-glutathionylation in tubulin or 
as a routine screen to determine S-glutathionylation in a specific tubulin segment or 
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Appendix A: Figures 
 
  
Figure 1: 1° amine biotinylation by reaction with sulfo-NHS-biotin 
Schematic showing generic amine biotinylation via nucleophilic attack to a carbonyl.  The 
mechanism of reaction with sulfo-NHS-biotin is analogous to that with NHS-biotin27. 
 
Figure 2: TLC plate of controls and C8 column separation 
Free amines are visualized by ninhydrin spray followed by heating.  The GSSG only control 
contains 5.0 mM GSSG (which is representative of the concentration GSSG initially present in 
reaction mixture) and the prominent GSSG spot is visible.  The whole reaction lane contains a 
sample of the reaction immediately following incubation.  A prominent band corresponding to 
BGSSG is visible.  The fraction lanes contain samples of each fraction from the C8 separation.  
Fractions 1 (load eluent) and 2 (water) show bands corresponding to BGSSG while fractions 3 
(water), 4 (MeOH), and 5 (MeOH) show no bands.    
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Figure 3: Schematic of species migration on TLC plate 
Summarizes positioning of various species and their general appearance (both in spot shape and 
color).   
 
Figure 4: HABA assay of C8 column fractions 
Each well contains 10 µL of 1:10 dilutions of each fraction and 90 µL of HABA/avidin solution.  
Fraction 2 (water) shows a strong positive for the presence of biotin and fraction 1 (load eluent) 












Figure 5: HABA assay of GSSG only control and reaction 
Each well contains 10 µL of 1:10 dilutions of either a 5 mM GSSG solution or the BGSSGB 
synthesis reaction immediately following incubation and 90 µL of HABA/avidin solution.  The 
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- - - - - + + (faint) 
TLC 
(BGSSG) 
+ (faint) + (faint) - - - - + 
HABA + (very 
faint) 
+ - - - - + 
 
Figure 6: Summary of TLC and HABA results for the C8 column extraction   
A “+” indicates either that a band was present on the TLC plate for that particular species or that 
the HABA assay indicated the presence of biotin.  A “-” indicates either that a band was absent 
on the TLC plate for that particular species or that the HABA assay was negative for the presence 






Figure 7: TLC plate of C18 column separation 
Each lane contains a sample of each fraction, and the plate is visualized by ninhydrin spray.  All 
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Figure 8:  HABA assay of C8 column fractions 
Each well contains 10 µL of 1:10 dilutions each fraction and 90 µL of HABA/avidin solution.  










Fraction 1 (load eluent) 2 (water) 3 (water) 4 (MeOH) 5 (MeOH) 
TLC (GSSG) - - - - - 
TLC (BGSSGB) - - - - - 
HABA + (very faint) + - - - 
 
Figure 9: Summary of TLC and HABA results for the C18 column extraction 
A “+” indicates either that a band was present on the TLC plate for that particular species or that 
the HABA assay indicated the presence of biotin.  A “-” indicates either that a band was absent 
on the TLC plate for that particular species or that the HABA assay was negative for the presence 
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Figure 10:  Solid-phase extraction summary 
Schematic showing the theoretical partitioning of species over the column chromatography 
procedure.   
 
 
Figure 11: SDS-PAGE of tubulin with biotin-labeled glutathione visualized 
Samples were run under non-reducing conditions in lanes 2 and 4 and contained 10 µL PB and 20 
µL 4 mg/mL tubulin.  Transferred bands were visualized on PVDF membrane via avidin-HRP 
conjugate.  Smear demonstrates need to run tubulin under reducing conditions.   
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Figure 12: SDS-PAGE of tubulin eluted from resin (Coomassie Blue staining) 
Both lanes are identical and consisted of 20 µL 4 mg/mL tubulin and 10 µL ~5 mM BGSSGB to 
which 20 µL avidin-agarose resin and 30 µL PB were added. Protein was visualized via 







Figure 13: SDS-PAGE of controls (Coomassie Blue staining) 
The tubulin only control contained 20 µL 4 mg/mL tubulin, 10 µL PB, and no resin was added.  
The no resin control contained 20 µL 4 mg/mL tubulin, 10 µL ~5mM BGSSGB, and no resin was 
added.  The no BGSSGB control contained 20 µL 4 mg/mL tubulin, 10 µL PB, and 20 µL resin 
was added.  Protein was visualized via Coomassie Blue staining.  Gel was 10% acrylamide and 
run under reducing conditions.   
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Figure 14: Dot blots after incubation and resuspension with biotin visualized 
1.5 µL of reaction was spotted onto a nitrocellulose membrane after the reactants were assembled 
and initially incubated and then again following ethanol precipitation and resuspension.  All 
samples contained 20 µL of 4 mg/mL tubulin.  The no resin control contained tubulin, 10 µL of 
~5 mM BGSSGB but ultimately no avidin-agarose resin was added.  The no BGSSGB control 
contained tubulin, 10 µL of PBS in the place of BGSSGB, and eventually 20 µL avidin-agarose 
resin.  Samples 1 and 2 were identical and contained tubulin, 10 µL ~5 mM BGSSGB, and 
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Figure 15: Dot blots after incubation and resuspension with β-tubulin visualized 
1.5 µL of reaction was spotted onto a nitrocellulose membrane after the reactants were assembled 
and initially incubated and then again following ethanol precipitation and resuspension.  All 
samples contained 20 µL of 4 mg/mL tubulin.  The no resin control contained tubulin, 10 µL of 
~5 mM BGSSGB, but ultimately no avidin-agarose resin was added.  The no BGSSGB control 
contained tubulin, 10 µL of PB in the place of BGSSGB, and eventually 20 µL avidin-agarose 
resin.  Samples 1 and 2 were identical and contained tubulin, 10 µL ~5 mM BGSSGB, and 
eventually 20 µL avidin-agarose resin. Protein was visualized via B-tubulin primary antibody and 
Goat-anti mouse secondary antibody.   
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Figure 16: Dot blots after resin incubation and first wash with biotin visualized 
1.5 µL of solution was spotted onto a nitrocellulose membrane from the reaction after incubation 
with the avidin-agarose resin and from the first wash.  All samples contained 20 µL of 4 mg/mL 
tubulin.  The no resin control contained tubulin, 10 µL of ~5 mM BGSSGB, but ultimately no 
avidin-agarose resin was added.  The no BGSSGB control contained tubulin, 10 µL of PB in the 
place of BGSSGB, and eventually 20 µL avidin-agarose resin.  Samples 1 and 2 were identical 
and contained tubulin, 10 µL ~5 mM BGSSGB, and eventually 20 µL avidin-agarose resin. 





















































Figure 10: Rasmol image of tubulin.  Protein in the foreground is β-tubulin and rear subunit is α-
tubulin.  Cys12 is highlighted in blue and is seen in close proximity to bound GDP which is 
highlighted in purple.  Cys129 is highlighted in red and is in close proximity to Cys131 which is 
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Appendix B: Abbrevations 
 
ADH: Alcohol dehydrogenase 
APP: Amyloid precursor protein 
BCA: Bicinchoninic acid 
BGSH: Biotin tagged reduced glutathione 
BGSSG: Singly biotin tagged oxidized glutathione 
BGSSGB: Doubly biotin tagged oxidized glutathione 
CK: Creatine kinase 
Cys: Cysteine 
DMF: Dimethylformamide (a solvent) 
DTNB: Ellman’s reagent 
DTT: Dithiothreitol (a reducing agent) 
FGSH:  Flourescein tagged reduced glutathione 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase 
GDP: Guanosine diphosphate 
GRS: Glutaredoxin reductase system 
Grx: Glutaredoxin 
GSH: Reduced glutathione 
GTP: Guanosine triphosphate 
HABA: 4´-hydroxyazobenzene-2-carboxylic acid 
HPLC: High pressure liquid chromatography 
HRP: Horseradish peroxidase 
LDH:  Lactate dehydrogenase 
MAP: Microtubule associated protein 
MeOH:  Methanol 
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NADPH: Nicotinamide adenine dinucleotide phosphate 
NHS: N-hydroxysuccinimide 
PBS: Phosphate buffered saline 
PVDF: Polyvinylidene fluoride 
SDS: Sodium dodecyl sulfate (a detergent) 
SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
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Appendix D: Biochemical Techniques Index 
  
 The following are brief descriptions of some of the more important techniques mentioned 
throughout the thesis.  
 
HABA Assay 
 The HABA assay is a convenient way to assess the amount of biotinylated species in a 
sample28.  HABA has an affinity for avidin and can bind to the protein at four sites28.  When 
HABA is bound to avidin, the complex absorbs strongly at 500 nm28.  However, with the addition 
of a biotinylated molecule, the biotin displaces the HABA due to its high affinity for avidin.  The 
HABA dye molecule without bound avidin does not absorb at 500 nm, thus the decrease in 
absorption at 500 nm can be correlated to biotin concentration28.  Qualitatively, the addition of 
biotin to the HABA/avidin solution leads to a color change from orange to yellow.  Thus, this 
assay can determine whether a sample contains a biotinylated species.   
 
BCA Assay 
 The BCA assay is traditionally used to measure total protein concentration29.  The assay 
is sensitive to a number of amino acids, including cysteine residues.  Because DTT contains a 
thiol (which is the functional group of a cysteine), the BCA assay indicates positive for DTT29.  
Thus, this technique can also assay for DTT in a solution and has the advantage of being quick 
and simple.  A color change from light green to a dark purple indicates presence of DTT.   
 
DTNB Assay 
 The DTNB assay uses 5,5'-Dithio-bis(2-nitrobenzoic acid), also known as Ellman’s 
reagent, to quantify cysteine residues in a sample30.  Reaction of DTNB with thiols leads to a 
decrease in absorbance at 412 nm, which can be correlated to the concentration of thiolcontaining 
species in a sample30.   
 
SDS-PAGE 
 SDS-PAGE is a form of polyacramide gel electrophoresis that has smaller pore sizes than 
gel electrophoresis and thus has better resolving power31.  In the process, proteins are denatured 
by SDS, a detergent, and are uniformly coated with negative charge31.  Proteins migrate across a 
charge gradient and are separated according to size.  Because SDS provides a uniform charge 
coating for the denatured proteins, size alone is the factor by which they are separated.  This 
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technique allows for identification of the types and relative amounts of proteins present in a 
particular sample.   
 Gels can be run under reducing or non-reducing conditions.  Running a gel under 
reducing conditions entails addition of a reducing agent to the sample just prior to loading31.  
Some proteins, such as tubulin, readily form higher order structures from air oxidation and 
require reduction before they are loaded onto a gel.   
 
Western Blot 
 A Western blot is a way to analyze proteins after they have been separated on a 
polyacrylamide gel.  Proteins are transferred to a membrane, generally PVDF, via either gravity 
or a charge gradient32.  Antibodies can then be applied which bind to their protein target.  To 
prevent antibodies from uniformly binding the membrane, which is absorbent to all protein, milk 
(which is very protein rich) is used to coat the membrane prior to antibody addition32.  This 
technique facilitates identification of specific proteins, protein subunits, or even post-translational 
modifications.   
 
Coomassie Blue Staining 
 Coomassie blue staining is a way to visualize proteins in a gel.  After proteins have fully 
migrated, polyacrylamide gels are placed in a solution containing Coomassie Brilliant Blue G-
25029.  The dye stains protein by binding non-covalently to amino and carboxyl groups29.  
Following dye binding, a destaining solution consisting of methanol and acetic acid is used to 
remove excess dye from the gel.  Proteins are visible as blue bands.  Gels can be then be archived 
through a gel drying procedure.   
 
Dot Blots 
 Dot blots are a method in which one can very quickly assess the presence of a protein in a 
sample.  Very small sample volumes are spotted onto a nitrocellulose membrane.  Washing the 
membrane with PBS leads to the dissociation of all non-protein molecules while the proteins are 
retained by the membrane.  Similarly to the Western technique, the membrane is blocked and 
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